Cg Bio Co., Ltd.

Bioalpha Corporation

The Asan Foundation

Snur & Db Foundation

Hyun Seung Ryu

Jun Hyuk Seo

Joon Pio Hong

Mi Young Ryu

Jun Kyu Park

Seok Beom Song

Jun Young Lim

Hak Su Jang

Su Hyun Jung

Jung Won So

Hee Jun Park

Yong Bok Kim

Soon Gee Hong

Sung Nam Park

Hoon Tae Kim

Tae Il Kim

Jung Yoon Kim

Kug Sun Hong

Ki Tae Nam

Hae Jun Jeong

Chang Hun Kum

Jae Hwa Cho

Hae Lin Jang

Kyoung Suk Jin

Weon Ik Choi

Wook Chun

Gyu Hyun Jin

Byoung Suck Kim

Deok Hee Lee

Ok Kyun Lim

Nam Yul Cho

Kang Jin Jeon

Baek Il Kim

Ga Young Lee

Han Ki Kim

So Myoung Lee

Myong Chul Park

Baek-Hyun Kim

Gyu Dong Jang

Byeong Woo Kwon

Bo Young Yoo

Young Koo Lee

Jong Ha Park

Seon Moon Hwang

Jung Ju Kim

Bo Yung Yoo

In Ho Kim

Yong Su Kim

The present invention relates to a glass ceramic composition comprising SiO, Ca(OH), CaF, BO, MgO, and hydroxyapatite; a bioactive crystallized glass ceramic comprising each of CaSiO, Ca(PO)(OH), and CaMgSiOin an amount of 20% to 60% by weight; an implant for early osseointegration comprising the glass ceramic; and a method for manufacturing the implant.

Bioactive crystallized glass ceramic comprising wollastonite, hydroxyapatite and diopside, and use thereof

A composition for a FDM 3D printer is disclosed. The composition contains bioglass and a biocompatible polymer resin. In addition, a FDM 3D printer molded article having a laminated strut structure, in which the composition for the FDM 3D printer is injected into four layers, is disclosed.

Composition for FDM 3D printer, method of manufacturing the same, and molded article

Provided are a hyaluronic acid composition having excellent viscoelasticity and being easily injectable, and a preparation method thereof.

Hyaluronic acid composition and preparation method therefor

The present invention relates to a wound dressing material comprising a fibrillated acellular dermis matrix and a biodegradable polymer aqueous solution and, more specifically, to: a wound dressing material comprising 5-20 wt % of a fibrillated acellular dermis matrix, 0.5-5 wt % of a biodegradable polymer, and 75-94.5 wt % of water; and a preparation method therefor.

Wound dressing material comprising fibrillated accellular dermis matrix and biodegradeable polymer, and preparation method therefor

The present invention relates to a system for producing artificial osseous tissue comprising: a client computer acquiring an image information of a subject bone tissue from an imaging unit that picks up an image of a subject bone tissue of a patient to generate a 3D image information; a server computer identifying the subject bone tissue based on the image information of the subject bone tissue received from the client computer, generating a 3D image information of at least one therapeutic bone tissue model corresponding to the subject bone tissue, and transmitting the 3D image information of the at least one therapeutic bone tissue model to the client computer; and a machining unit for fabricating an artificial bone tissue based on the 3D image information of the therapeutic bone tissue model determined from the server computer.

System for producing artificial osseous tissue and method for producing same

The disclosure relates to a cervical spine fixation apparatus comprising: a body; a spacer; and a frame which is positioned on the lateral side of the spacer and couples with the spacer, wherein the frame has a coupling part for coupling with the body, and the body comprises a hole in which the coupling part of the frame is inserted. Or, the disclosure relates to a cervical spine fixation apparatus comprising: a body; and a spacer having a coupling part, wherein the body comprises a hole in which the coupling part is inserted, and the spacer moves with respect to the body.

Cervical spine fixation apparatus

Disclosed is a scaffold for living donor transplantation, which includes sintered bioglass and a biocompatible polymer and has improved properties using a 3D printer through a fused deposition modeling process.

Scaffold for living donor transplantation

The present invention relates to a wound volume measuring method and device, wherein the method comprises the steps of: disposing a foam dressing on a wound site; hermetically sealing the wound site by attaching a film dressing on skin adjacent to the wound site; supplying a negative pressure to the hermetically sealed space formed between the film dressing and the wound site, and thereby discharging fluid into the hermetically sealed space; measuring the flow of the fluid discharged from the hermetically sealed space; and calculating the volume of the wound site on the basis of the measured fluid flow.

Wound volume measuring method and device

The present invention relates to a method for preparing a medical material for replacing a hard tissue defect and a medical material produced therefrom. More specifically, in the present invention, powders of bioactive glass are press-molded, and are then subjected to a first heat treatment at a relatively low temperature below the glass transition temperature of bioactive glass. Then, the resultant is processed into a desired shape and then subjected to a second heat treatment at a temperature higher than the glass transition temperature of bioactive glass. Accordingly, the present invention provides a medical material which can be customized to a desired shape of a hard tissue defect in a living body and minimize thermal shock, and which is capable of exhibiting a bone fusion property, while overcoming the low compressive strength drawback of hydroxyapatite, which is an existing hard tissue replacement material currently in use.

Method for preparing a medical material for replacing a hard tissue defect and a medical material prepared therefrom

A hybrid stent includes multiple main cells aligned in a spiral shape and including multiple first link units which are aligned diagonally and spaced at a predetermined distance from each other and multiple second link units which connect adjacent first link units among the multiple first link units and are spaced at a predetermined distance from each other, and one or more open cells adjacent to the multiple main cells in a longitudinal direction and aligned in a spiral shape.

Hybrid stent

The present invention relates to a crystallized glass ceramic comprising 30 wt % to 40 wt % of each of CaSiO, Ca(PO)(OH), and CaMg(SiO); a crystallized glass ceramic composition comprising CaSiO, Ca(PO)(OH), and CaMg(SiO) in a predetermined weight ratio; a bone graft material comprising the glass ceramic; and an intervertebral spacer or medical device for replacement of bone tissue, which is manufactured using the bone graft material.

High-strength crystallized glass ceramic comprising wollastonite, hydroxyapatite and akermanite

The present invention relates to a carrier for growth factor related to regeneration of bone tissues that is capable of arbitrarily controlling the delivery rate of growth factors related to bone regeneration and thus especially applicable to a bone void filler in the fields of the dental or orthopedic applications. The carrier for controlling the delivery rate of the growth factor in the present invention is composed of a hyaluronic acid hydrogel having a distribution of interconnected pores and a calcium phosphate microsphere being distributed in the pores of the hyaluronic acid hydrogel. The calcium phosphate microsphere having a porosity suitable for delivery of the growth factor is positioned into the pores of the cross-linked hyaluronic acid hydrogel to complete the carrier.

Hyaluronic acid-calcium phosphate composite for growth factor support and method for producing same

The present invention relates to a bone graft composition and a preparation method thereof, and more particularly to a bone graft composition having excellent physical properties, which comprises a hydrogel comprising a combination of specific amounts of poloxamer and HPMC, and calcium phosphate compound particles, and a preparation method thereof.

Bone graft composition and preparation method thereof

The present invention relates to a method for producing an acellular dermal matrix, and to an acellular dermal matrix produced by same, and more particularly, to a method for producing an acellular dermal matrix, in which sucrose is added to base ingredients consisting of glycerol, propylene glycol, and a base solvent or solution so as to produce a cryoprotectant, the solution is injected into the skin below the epidermis and dermis from which cells have been removed, and freeze-drying is then performed.

Method for producing an acellular dermal matrix, and acellular dermal matrix produced by same

The present invention relates to an antimicrobial wound dressing comprising chitosan-silver nanoparticles and a preparation method thereof The antimicrobial wound dressing is prepared by coating a wound dressing with chitosan and silver and drying the coated wound dressing and has an excellent property of releasing silver nanoparticles in a sustained manner.

Antimicrobial wound-covering material and method for manufacturing same

Growing community of inventors

Gyeonggi-do, South Korea

Hyun Seung Ryu